Oresund Pharma
Oresund Pharma is a privately owned Copenhagen-based pharmaceutical company that distributes, in-licenses, and acquires branded pharmaceutical products for all five Nordic markets (Denmark, Finland, Iceland, Norway, Sweden), serving pharmacies, hospitals, and international pharmaceutical principals via a GDP-certified supply chain.
- Company typePrivate
- Founded2018
- HeadquartersCopenhagen, Denmark
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Oresund Pharma does
Oresund Pharma ApS is a privately owned Danish pharmaceutical distribution and commercialization company founded by brothers Svend and Patrick Johansen. Headquartered in Copenhagen's Nordhavn district, the company serves as a full-service market-entry and distribution partner for international pharmaceutical principals seeking access to the five Nordic markets—Denmark, Finland, Iceland, Norway, and Sweden—collectively representing a pharmaceutical market of approximately €10 billion (2019) and a population of 26.5 million.
The company operates three interlocking business lines: (1) exclusive distribution agreements channeling pharmaceutical products from international principals through GDP-certified pre-wholesalers and wholesalers to pharmacies and hospitals; (2) in-licensing of new prescription and OTC products with a value-added component; and (3) acquisition and integration of established branded pharmaceuticals serving specific unmet Nordic needs. Its product portfolio spans originator products and carefully selected generic substances across therapeutic areas including Cardiovascular, Infectious Diseases, Musculo-skeletal, Neurology, and Oncology.
Operationally, Oresund Pharma integrates sales, marketing, warehousing, logistics, finance, regulatory affairs, and pharmacovigilance under a single lean structure of 1–10 employees, supported by a dedicated pan-Nordic sales force collaborating directly with healthcare professionals and specialists. The technology stack centers on GDP-certified quality systems and regulatory compliance frameworks aligned with EU/EEA, GMP, and Danish Medicines Act requirements. Revenue is generated through distribution margins, licensing royalties, and one-time payments for acquired branded products, with no disclosed pricing transparency given the B2B partnership model.
Oresund Pharma firmographics
Firmographics- Name
- Oresund Pharma
- Legal name
- Oresund Pharma ApS
- Website
- https://www.oresundpharma.com/
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Oresund Pharma is a privately owned Copenhagen-based pharmaceutical company that distributes, in-licenses, and acquires branded pharmaceutical products for all five Nordic markets (Denmark, Finland, Iceland, Norway, Sweden), serving pharmacies, hospitals, and international pharmaceutical principals via a GDP-certified supply chain.
- Ownership category
- akta.pro rank
Oresund Pharma industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)
Keywords
Where Oresund Pharma is headquartered
LocationHeadquarters
- HQ city
- Copenhagen
- HQ country
- Denmark
- HQ region
- Europe
Offices2 records
Markets served
Oresund Pharma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Pharmaceutical Distribution: Distribution of pharmaceuticals from industry partners through exclusive distribution agreements across Nordic markets. Revenue generated through distribution fees and margins on pharmaceutical products sold through their network.
- Product In-licensing: In-licensing of new pharmaceutical products including prescription drugs and OTC products, adding to product portfolio and generating revenue through sales.
- Pharmaceutical Acquisitions: Acquisition and integration of established branded pharmaceuticals serving specific market needs, generating revenue through commercialization of acquired products.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels2 records
Oresund Pharma product offering
Product offeringCore offering
Oresund Pharma is a privately owned Nordic pharmaceutical company that provides sales, distribution, and commercialization services for pharmaceutical products across all five Nordic countries (Denmark, Finland, Iceland, Norway, Sweden). The company works with international pharmaceutical partners through exclusive distribution agreements, in-licensing arrangements, and product acquisitions to deliver prescription medicines, OTC products, originator brands, and generic pharmaceutical substances spanning therapeutic areas such as cardiovascular, infectious diseases, neurology, oncology, and musculo-skeletal care.
Product overview
Oresund Pharma is a privately owned Danish pharmaceutical company that operates as a full-service pharma partner serving all five Nordic markets (Denmark, Finland, Iceland, Norway, and Sweden). The company offers a combination of originator products and carefully selected generic substances through its core product categories: prescription medicines, OTC products, hospital products, and retail pharmacy products. Its product portfolio spans multiple therapeutic areas including Cardiovascular, Infectious Diseases, Musculo-skeletal, Neurology, and Oncology. Beyond product distribution, the company provides complementary services including in-licensing, acquisitions of branded pharmaceuticals, regulatory support, pharmacovigilance, and supply chain management. The business model is built on partnering with international pharmaceutical companies seeking Nordic market representation through exclusive distribution agreements.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Distribution Services Exclusive distribution of pharmaceutical products from international industry partners across the Nordic region, delivered via GDP-licensed pre-wholesalers and wholesalers to pharmacies and hospitals. The service handles warehousing, logistics, inventory management, regulatory compliance, and tender management for the principal's products.
- Pharmaceutical In-licensing Services In-licensing of new prescription and over-the-counter pharmaceutical products to add to the Oresund Pharma portfolio. The service seeks products with a value-added component for the Nordic region and adds them to the company's commercialization pipeline.
- Acquisition of Branded Pharmaceuticals Identification, acquisition, and integration of established and mature branded pharmaceutical products serving specific unmet needs in the Nordic market, adding them to the company's product portfolio.
- Nordic Pharmaceutical Product Portfolio Portfolio of originator brand-name and selected generic pharmaceutical products distributed across the Nordic region, covering prescription medicines and OTC products for hospital clinics and retail pharmacies. The portfolio spans therapeutic areas including cardiovascular, infectious diseases, musculo-skeletal, neurology, and oncology.
Quantifiable outcome
- Full coverage of €10 billion Nordic pharmaceutical market
- +1 more outcomes
Companies that use Oresund Pharma
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
Oresund Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Oresund Pharma partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Pharmaceutical Industry Partners (unspecified)coreOresund Pharma distributes pharmaceuticals from industry partners through exclusive distribution agreements. Partners aim to be locally represented in the Nordics and benefit from Oresund Pharma's infrastructure, market knowledge, and regulatory expertise.
- Pre-wholesalers and WholesalerscoreDistribution of medicines through pre-wholesalers and wholesalers approved and licensed by The Medicines Act and in compliance with Good Distribution Practice. These partners are essential for reaching pharmacies and hospitals across the Nordic region.
- Licensed Pharmaceutical SupplierscoreOresund Pharma only engages with licensed and compliant companies. All pharmaceutical products are transported, stored and documented with GDP-certified quality systems. Partners benefit from effortless access to the Nordic market with steady demand in a complex pricing environment.
Scale indicators4 records
Oresund Pharma competitors and assessment
Company assessmentBroad incumbents
- McKesson Corporation: Global pharmaceutical distributor and healthcare services company with extensive wholesale operations in Europe. Comparable business model to Oresund Pharma's wholesale distribution, but at vastly greater scale and geographic reach.
- Mediq: European distributor of pharmaceuticals, medical devices, and specialty healthcare products (now under PE ownership). Comparable cross-border distribution model to Oresund Pharma, but serving multiple European healthcare segments at greater scale.
- Alliance Healthcare: European pharmaceutical wholesaler and pharmacy operator owned by Walgreens Boots Alliance, with distribution across multiple European markets. Comparable wholesale and pharmacy supply model to Oresund Pharma, though at greater scale.
- STADA Arzneimittel: European specialty pharmaceutical company focused on generics, consumer health, and specialty pharma with established distribution. Comparable to Oresund Pharma on specialty pharma in-licensing and portfolio focus, but at much broader European scale.
- Cencora: Global pharmaceutical distribution and consulting firm (formerly AmerisourceBergen) with strong European wholesale presence. Provides the same wholesale distribution backbone as Oresund Pharma but at global scale with far broader services.
- Phoenix Group: One of Europe's largest pharmaceutical distributors with pan-European wholesale operations, including pharmacy retail. Comparable to Oresund Pharma at scale, but operating across a much broader geography and product portfolio.
Regional players
- EBOS Group: Australasian healthcare and pharmaceutical distributor with wholesale, specialty, and consumer health operations. Comparable multi-channel distribution model to Oresund Pharma, but operating in a different geography (Australia/New Zealand).
Emerging players
- Unimedic Pharma: Swedish specialty pharma company with distribution and licensing operations across the Nordics. Closely comparable to Oresund Pharma on Nordic specialty pharma focus, though with proprietary product development alongside distribution.
- Orion Corporation: Finnish-headquartered global health and pharma company with proprietary products plus Nordic distribution. Comparable on Nordic focus and therapeutic breadth, though Orion is primarily a manufacturer rather than a distributor.
Direct peers
- Oriola Corporation: Finland-headquartered pharmaceutical distributor (formerly Tamro) operating across the Nordic and Baltic markets with wholesale, distribution, and pharmacy services — directly comparable to Oresund Pharma's Nordic wholesale/distribution model.
Market position
Strengths4 records
Weaknesses4 records
Key risks6 records
Key highlights5 records
Customer concentration
Oresund Pharma social profiles
Digital presenceOresund Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Oresund Pharma leadership team
Management profileNumber of profiles
Profiles2 records
Oresund Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Oresund Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Oresund Pharma
What does Oresund Pharma do?
Oresund Pharma is a privately owned Nordic pharmaceutical company that provides sales, distribution, and commercialization services for pharmaceutical products across all five Nordic countries (Denmark, Finland, Iceland, Norway, Sweden). The company works with international pharmaceutical partners through exclusive distribution agreements, in-licensing arrangements, and product acquisitions to deliver prescription medicines, OTC products, originator brands, and generic pharmaceutical substances spanning therapeutic areas such as cardiovascular, infectious diseases, neurology, oncology, and musculo-skeletal care.
Is Oresund Pharma a public or private company?
Oresund Pharma is a private company. It is classified as family owned and is currently operating.
When was Oresund Pharma founded?
Oresund Pharma was founded in 2018. It employs 1 to 10 people.
Where is Oresund Pharma based?
Oresund Pharma is headquartered in Copenhagen, Denmark, in the Europe region.
How does Oresund Pharma make money?
Three revenue lines are on record. Pharmaceutical Distribution is the primary driver. The others are product In-licensing and pharmaceutical Acquisitions.
Who are Oresund Pharma's main competitors?
Broad incumbents on record are McKesson Corporation, Mediq, Alliance Healthcare, STADA Arzneimittel, Cencora and Phoenix Group. EBOS Group is listed as a regional player. Emerging players are Unimedic Pharma and Orion Corporation. Oriola Corporation is listed as a direct peer.
Does Oresund Pharma have an API?
No public API is recorded for Oresund Pharma.
What industry is Oresund Pharma in?
Oresund Pharma's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant). Its NAICS code is 424210 and its SIC code is 5122.